Stay updated with breaking news from Aapge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $56.37, but opened at $52.55. Apogee Therapeutics shares last traded at $54.12, with a volume of 23,188 shares changing hands. Analyst Ratings Changes Several analysts have recently issued reports on […]
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in […]
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have earned an average recommendation of “Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the […]
Investor interest in newly-issued biotech stocks has been moribund for years, but the sector’s first IPO of 2024, CG Oncology, suggests that investors might...
Apogee Therapeutics (NASDAQ:APGE – Free Report) had its target price boosted by Guggenheim from $29.00 to $44.00 in a report released on Wednesday morning, Benzinga reports. Guggenheim currently has a buy rating on the stock. A number of other analysts have also commented on APGE. Wedbush reissued an outperform rating and set a $40.00 price […]